1 / 16

Synthesizing Human Insulin

Synthesizing Human Insulin. by Molly Nicholson With the Duke Institute for Genome Sciences & Policy Center for Genome Ethics, Law & Policy. Agenda. The players—Harvard, UCSF, Genentech Basic timeline Key hurtles Individual strategies Outcome Conclusions Sources and further research.

gage
Télécharger la présentation

Synthesizing Human Insulin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Synthesizing Human Insulin by Molly Nicholson With the Duke Institute for Genome Sciences & Policy Center for Genome Ethics, Law & Policy

  2. Agenda • The players—Harvard, UCSF, Genentech • Basic timeline • Key hurtles • Individual strategies • Outcome • Conclusions • Sources and further research

  3. The Players • University of California San Francisco • Genentech, Inc. • Harvard Biology Laboratories • Also…Eli Lilly and Company, Biogen, Novo Industri, Nordisk

  4. Major Milestones January 1977 Cloning of rat insulin October 1977 Synthesis of human somatostatin May 1978 Expression of rat insulin in bacteria August 1978 Synthesis of human insulin!

  5. Key Factors • Open sharing of data • Government regulation • Relationship with the public and media • Intellectual Property • Business and Academia

  6. The Harvard Biology Laboratories

  7. Harvard • Moratorium on recombinant DNA research and P-3 laboratory facility • Patents • “Protein synthesis” (1983) • “Recombinant DNA molecule” (1986) • Biogen • The Midnight Hustler

  8. University of California San Francisco Medical Sciences Building ? William Rutter Chair of the Department of Biochemistry and Biophysics Howard Goodman Associate professor of Biochemistry

  9. UCSFThe Rutter and Goodman Labs • pBR 322 • Howard Goodman • Negotiations and agreements with Eli Lilly and Genentech, Inc. • Regents of the University of California v. Eli Lilly and Company (1990) Axel Ullrich

  10. Genentech, Inc.UCSF and City of Hope National Medical Center Herbert Boyer Co-founder of Genentech, Inc., and UCSF professor of biochemistry Bob Swanson Founder of Genentech, Inc.

  11. Genentech, Inc. • Difficulties separating from UCSF • Herb Boyer • Active recruiting • City of Hope lawsuit

  12. Outcome • Genentech wins! • UCSF loses: • Weak patents • Harvard loses: • Fails to clone human insulin first

  13. Conclusions • UCSF lost because: • Weak patent management and application • Lack of open data sharing led to tense working environment • Howard Goodman • Harvard lost because: • Government regulation

  14. Sources • Stephen Hall, Invisible Frontiers: The Race to Synthesize a Human Gene (1987) • Judge Hugh S. Dillin’s Memorandum of Opinion re. Regents of the University of California v. Eli Lilly and Company • Oral histories collected by Sally Smith Hughes at UC Berkeley Libraries

  15. Further Research Scheduled interviews with: • Walter Gilbert (Harvard) • John Baxter (UCSF) Administrators at the patent/technology transfer offices at UCSF, Harvard and Genentech

  16. Questions?

More Related